Furthermore, the pharmacology in the Lively factors was mainly uncharacterized, and confirmation of SCB use was hindered by an absence of acknowledged biomarkers. These expertise gaps prompted experts across multiple disciplines to promptly (1) monitor, identify and quantify with chromatography/mass spectrometry the ever-modifying contents of herba